Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy.

Sun, Jennifer K; Glassman, Adam R; Beaulieu, Wesley T; Stockdale, Cynthia R; Bressler, Neil M; Flaxel, Christina; Gross, Jeffrey G; Shami, Michel; Jampol, Lee M

Sun, Jennifer K; Glassman, Adam R; Beaulieu, Wesley T; Stockdale, Cynthia R; Bressler, Neil M; Flaxel, Christina; Gross, Jeffrey G; Shami, Michel; Jampol, Lee M.

Affiliation

Sun JK; Joslin Diabetes Center, Beetham Eye Institute, Department of Ophthalmology, Harvard University, Boston, Massachusetts.
Glassman AR; Jaeb Center for Health Research, Tampa, Florida.
Beaulieu WT; Jaeb Center for Health Research, Tampa, Florida. Electronic address: drcrstat8@jaeb.org.
Stockdale CR; Jaeb Center for Health Research, Tampa, Florida.
Bressler NM; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Flaxel C; Casey Eye Institute, Portland, Oregon.
Gross JG; Carolina Retina Center, PA, Columbia, South Carolina.
Shami M; Texas Retina Associates, Lubbock, Texas.
Jampol LM; Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Ophthalmology ; 126(1): 87-95, 2019 01.

Article in En | MEDLINE | ID: mdl-30096354

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Algorithms / Retinal Neovascularization / Angiogenesis Inhibitors / Diabetic Retinopathy / Ranibizumab Type of study: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Ophthalmology Year: 2019 Document type: Article Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google